These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 34432161)

  • 1. PARP1-modulated chromatin remodeling is a new target for cancer treatment.
    Sinha S; Molla S; Kundu CN
    Med Oncol; 2021 Aug; 38(10):118. PubMed ID: 34432161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance.
    Andronikou C; Rottenberg S
    Trends Mol Med; 2021 Jul; 27(7):630-642. PubMed ID: 34030964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PARP Way to Epigenetic Changes.
    Ummarino S; Hausman C; Di Ruscio A
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33804735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Talazoparib enhances the quinacrine-mediated apoptosis in patient-derived oral mucosa CSCs by inhibiting BER pathway through the modulation of GCN5 and P300.
    Das C; Dash SR; Sinha S; Paul S; Das B; Bhal S; Sethy C; Kundu CN
    Med Oncol; 2023 Nov; 40(12):351. PubMed ID: 37940725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
    Jain PG; Patel BD
    Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions.
    Zentout S; Imburchia V; Chapuis C; Duma L; Schützenhofer K; Prokhorova E; Ahel I; Smith R; Huet S
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2322689121. PubMed ID: 38865276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells: implications for their use in combination with PARP inhibitors and chemotherapeutic drugs.
    Valdez BC; Nieto Y; Yuan B; Murray D; Andersson BS
    Oncotarget; 2022 Oct; 13():1122-1135. PubMed ID: 36243940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine-linked PARP1 auto-modification controls PARP inhibitor response.
    Prokhorova E; Zobel F; Smith R; Zentout S; Gibbs-Seymour I; Schützenhofer K; Peters A; Groslambert J; Zorzini V; Agnew T; Brognard J; Nielsen ML; Ahel D; Huet S; Suskiewicz MJ; Ahel I
    Nat Commun; 2021 Jul; 12(1):4055. PubMed ID: 34210965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olaparib enhances curcumin-mediated apoptosis in oral cancer cells by inducing PARP trapping through modulation of BER and chromatin assembly.
    Molla S; Chatterjee S; Sethy C; Sinha S; Kundu CN
    DNA Repair (Amst); 2021 Sep; 105():103157. PubMed ID: 34144488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of regulaion of transcription by PARP1].
    Maliuchenko NV; Kulaeva OI; Kotova E; Chupyrkina AA; Nikitin DV; Kirpichnikov MP; Studitskiĭ VM
    Mol Biol (Mosk); 2015; 49(1):99-113. PubMed ID: 25916114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging.
    Zhang H; Lin X; Zha S
    Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.
    Hu K; Wu W; Li Y; Lin L; Chen D; Yan H; Xiao X; Chen H; Chen Z; Zhang Y; Xu S; Guo Y; Koeffler HP; Song E; Yin D
    EMBO Rep; 2019 May; 20(5):. PubMed ID: 30940648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parp1 Deficiency Confers Defects in Chromatin Surveillance and Remodeling During Reprogramming by Nuclear Transfer.
    Osada T; Nozaki T; Masutani M
    Curr Protein Pept Sci; 2016; 17(7):693-704. PubMed ID: 27090907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications.
    Piao L; Fujioka K; Nakakido M; Hamamoto R
    Front Biosci (Landmark Ed); 2018 Jan; 23(1):13-26. PubMed ID: 28930534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.
    Ahel D; Horejsí Z; Wiechens N; Polo SE; Garcia-Wilson E; Ahel I; Flynn H; Skehel M; West SC; Jackson SP; Owen-Hughes T; Boulton SJ
    Science; 2009 Sep; 325(5945):1240-3. PubMed ID: 19661379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification.
    Rouleau-Turcotte É; Pascal JM
    J Biol Chem; 2023 Dec; 299(12):105397. PubMed ID: 37898399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.
    Kim IK; Stegeman RA; Brosey CA; Ellenberger T
    J Biol Chem; 2015 Feb; 290(6):3775-83. PubMed ID: 25477519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on Poly(ADP-ribose) Polymerase I-A Brief Review.
    Negi P; Lakshmanan K; Patel PK; Rajagopal K; Byran G
    Mini Rev Med Chem; 2023; 23(18):1762-1771. PubMed ID: 36824002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.